Foghorn Therapeutics Inc (FHTX) — Financial Flexibility Index
Foghorn Therapeutics Inc (FHTX) has a Financial Flexibility Index of -0.07x as of December 2025. Free cash flow of $-22.27 Million (operating CF $-22.27 Million minus capex $0.00) represents 0% of total liabilities ($306.60 Million). Also explore Foghorn Therapeutics Inc (FHTX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Foghorn Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Foghorn Therapeutics Inc across 8 annual periods. Check Foghorn Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Foghorn Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Foghorn Therapeutics Inc. For the full company profile including market capitalisation, see how much is Foghorn Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-86.05 Million | $-86.10 Million | $306.60 Million | ▲ +7.1% |
| 2024 | -0.30x | $-99.50 Million | $-100.41 Million | $329.51 Million | ▲ +6.2% |
| 2023 | -0.32x | $-116.88 Million | $-118.11 Million | $363.11 Million | ▼ -166.9% |
| 2022 | 0.48x | $194.82 Million | $193.61 Million | $404.77 Million | ▲ +533.7% |
| 2021 | -0.11x | $-46.94 Million | $-50.25 Million | $422.90 Million | ▲ +19.6% |
| 2020 | -0.14x | $-15.10 Million | $-31.29 Million | $109.41 Million | ▲ +66.4% |
| 2019 | -0.41x | $-45.37 Million | $-46.34 Million | $110.36 Million | ▼ -60.4% |
| 2018 | -0.26x | $-21.11 Million | $-22.65 Million | $82.33 Million | — |